Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News Feature articles General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Contemporary Challenges May Dim Prospects in the Year of the Water Dragon Chief Editor James Shen offers his annual comprehensive review of the Chinese pharma/healthcare sector in 2011 as well as outlook observations for the new year and beyond... (1/23/2012) Review of Chinese pharma deals, R&D and regulatory developments in 2011 (1/26/2012) Contemporary Challenges May Dim Prospects in the Year of the Water Dragon (1/23/2012) IMS Health: China Pharmaceutical Market Snapshot in Q3/2011 (1/23/2012) China Learns the Lesson of Vaccine R&D Bubble - The Story of Chongqing Brewery's in Development of Its Novel HepB Vaccine (1/17/2012) OneMedPlace China Forum - Pharma Faces China Healthcare Challenge (1/11/2012) When Old Dogs Meet New Tricks - 2011 Academic Marketing Recognition Ranking for International Pharmaceutical Companies in China (1/11/2012) Research Partnership between BMS and Simcere: The Right Chemistry Amid A Global Paradim Shift of Drug R&D (1/9/2012) Pharmaceutical Executive: Hard Times Before the Harvest for Pharma in 2012 (1/9/2012) Long Term Outlook Remains Positive for MNCs Despite Pricing Pressures and Uncertainties (12/31/2011) Chinese Pharma Espionage? (12/15/2011) Chinese Physicians Are More Digitally Savvy Than You Think (12/8/2011) Review of Chinese Pharma Industry Performance in the First Three Quarters (12/7/2011) SMEI Ranks Top 100 Chinese Retail Pharmacy Chains 2011 (12/2/2011) China's Healthcare Outlook in 2012 (11/29/2011) China Healthcare Prospects under Clouds of Slower Growth, Falling Profits, Stagnant Reform and Economic Uncertainties (11/25/2011) Global pharma deal-making fell 18% in 2011  (1/27/2012) New study: drug companies expand use of strategic partnerships  (1/27/2012) Major drug regulations and laws currently under drafting process in 2012  (1/26/2012) Data snapshot: hospital oncology drug consumption of six cities in Yangtze River vicinity  (1/26/2012) Upcoming event: Pharma China Seminar 2011 in NJ on April 29  (1/25/2012) (free) Upcoming event: Pharma China Annual Forum 2012 on March 30 in Shanghai  (1/25/2012) (free) Recent executive moves  (1/24/2012) New report: antithrombotic drug market will rise to 24.4B in 2015  (1/20/2012) Global pharma deal-making fell 18% in 2011 New study: drug companies expand use of strategic partne... New report: antithrombotic drug market will rise to 24.4... Takeda structures to integrate acquired Nycomed Pharma M&As rebouned in 2011 with surging BRIC deals... Data snapshot: hospital oncology drug consumption of six cities... Chinese pharma growth expected to slow mildly in 2012 Barclays Capital: Downside to prevail in 2012 for China healthc... Chinese Pharma import and export jumped 40% in the first ten mo... Chinese online retail drug sales estimated to be around CNY 400... Sinochem, DSM forms strategic alliance for biotech business MIIT issues the 12th FYP for the Chinese pharmaceutical indu... Novartis gains Chinese approval for Lucentis as it launches ... HUYA Bioscience establishes partnership with Tianjin Institu... Quintiles opens a center of excellence in Dalian Major drug regulations and laws currently under drafting... SFDA to launch a nationwide correction campaign as it la... SFDA issues notice to strengthen regulation of API mixed... China suspends approval and clinical trial of stem cell ... SFDA studies the MAH model for drug approval Former Sanofi researcher face prison sentence for technology... USTR Issues Report on China's Compliance with WTO and TRIPS Sihuan Bio sues Vitapharm for patent scam Foreign companies have an upper hand in the Chinese biopharm... Recent Chinese police raids seize CNY 2 billion worth of cou... Dishman close to a deal selling its brand new Chinese AP... India to inspect six Chinese API manufacturing facilitie... Shanghai Pharma acquires oncology API maker Chinese pharma companies targeted by environmental agenc... Chinese API sector expected to grow 20% in 2011 China approves the world's first hepetitis E vaccine Sinovac initiates phase III clinical research for its EV... Simcyp launches virtual Chinese patient population tool GSK China R&D partners with ProteoTech for new Parki... Two new pharmaceutical research institutions established... Health Minister Chen Zhu reviews healthcare reform achie... MOH bans officials from any involvements with drug procu... MOH issues guidelines for clinical cancer pain managemen... Shenzhen plans to remove drug sales margins in public ho... Beijing switches civil servants to BMI as the city raise... Recent executive moves Recent official and executive moves Guangzhou Pharma appoints Ferid Murad to head its research... Executive moves Executive moves Upcoming event: Pharma China Seminar 2011 in NJ on April... Upcoming event: Pharma China Annual Forum 2012 on March ... China's urban population exceeds rural residents for the... Upcoming Event: 4th Vaccines China 2012 Upcoming Event: Biosimilars Asia 2012 Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON officially publishes Chi...   WiCON publishes China Pharmace...   Pharma China adds one more dis...   WiCON Launches China Pharmaceu...   Pharma China adds another dist...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links